Long-Term Survival of PD-1 Inhibitor Combined with Antiangiogenic Agents in a Patient with Pulmonary Sarcomatoid Carcinoma Complicated with Esophageal Cancer: A Case Resport and Literature Review
Shuyue Jiao(Henan Cancer Hospital), Hong Tang(First Affiliated Hospital of Jiangxi Medical College), Xiao Zhang(Guangdong General Hospital), Ruilin Wang(Henan Cancer Hospital), Hui Zhu(Sun Yat-sen University), Shaomei Li(Huazhong Agricultural University)
Cited by 0
Related Papers
Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma
|Cancer Research|2022|108
Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validation
|Lung Cancer|2019|102
Laminin γ2–mediating T cell exclusion attenuates response to anti–PD-1 therapy
|Science Advances|2021|85
Transcriptome Reveals Long Non-coding RNAs and mRNAs Involved in Primary Wool Follicle Induction in Carpet Sheep Fetal Skin
|Frontiers in Physiology|2018|84
Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma
|Biochemical and Biophysical Research Communications|2015|55